Mouse studies and the development of weight-loss drugs like Fen-Phen validated the serotonin receptor 2C (HTR2C) protein as an anti-obesity drug target (Miller 2005). This evidence concerns the gene HTR2C and obesity due to melanocortin 4 receptor deficiency.